Retinal angiomatous proliferation patients may be treated with three consecutive loading doses of intravitreal ranibizumab

TORONTO — Three consecutive loading doses of intravitreal ranibizumab may be a treatment option for patients with retinal angiomatous proliferation, according to a poster presentation.Patients with stage 1 retinal angiomatous proliferation had a lower number of treatments and, therefore, lower recurrence rates than those in stage 2 and stage 3, Young Gun Park, MD, and colleague, said in a poster presented at the American Society of Retina Specialists meeting. Retrospective chart reviews of 41 eyes from 40 patients with a mean age of 67.09 were included in the study.

Full Story →